/cloudfront-us-east-2.images.arcpublishing.com/reuters/Y322Q2YMYVJJRLTIY2OUOL7ZP4.jpg)
A vial and a syringe are seen in front of a displayed Novavax logo, in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration
NEW DELHI, Dec 1 (Reuters) – (This Nov. 30 story has been officially corrected to remove reference to COVAX from headline and lead after Indian government clarifies it was a bilateral deal between Serum and Indonesia)
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax (NVAX.O) shot, the Indian government said on Wednesday.
The world’s biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last week.
Indonesia has approved the vaccine but India and the World Health Organization have not.
Register now for FREE unlimited access to reuters.com
Reporting by Krishna N. Das; Editing by Clarence Fernandez
Our Standards: The Thomson Reuters Trust Principles.
A vial and a syringe are seen in front of a displayed Novavax logo, in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/IllustrationNEW DELHI, Dec 1 (Reuters) – (This Nov. 30 story has been officially corrected to remove reference to COVAX from headline and lead after Indian government clarifies it was a bilateral deal between Serum and Indonesia)Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax (NVAX.O) shot, the Indian government said on Wednesday.The world’s biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last week.Indonesia has approved the vaccine but India and the World Health Organization have not.Register now for FREE unlimited access to reuters.comReporting by Krishna N. Das; Editing by Clarence FernandezOur Standards: The Thomson Reuters Trust Principles.